WHITEHAWK THERAPEUTICS, INC. Impairment of Intangible Assets (Excluding Goodwill)
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Impairment of Intangible Assets (Excluding Goodwill) of $0 for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2023-11-08
- WHITEHAWK THERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2023-09-30 was $0.00.
- WHITEHAWK THERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2023-03-31 was $3.70M, a 95.01% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2022-12-31 was -$24.00K.
- WHITEHAWK THERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2021 was $74.16M.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 6 month | Impairment of Intangible Assets (Excluding Goodwill) 9 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | $3.68M derived: sum of 4 quarters · filed 2023-11-08 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $3.68M derived: sum of 3 quarters · filed 2023-11-08 | $3.68M derived: sum of 4 quarters · filed 2023-11-08 | ||
| 2023-03-31 | $3.70M 10-Q · filed 2023-05-10 | $3.68M derived: sum of 2 quarters · filed 2023-11-08 | $3.68M derived: sum of 3 quarters · filed 2023-11-08 | $7.40M derived: sum of 4 quarters · filed 2023-11-08 | ||
| 2022-12-31 | -$24.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2023-11-08 | -$24.00K derived: sum of 2 quarters · filed 2023-11-08 | $3.70M derived: sum of 3 quarters · filed 2023-11-08 | $3.70M 10-Q · filed 2023-11-08 | $3.72M 10-K · filed 2023-03-29 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | $3.72M derived: sum of 2 quarters · filed 2023-11-08 | $3.72M 10-Q · filed 2023-11-08 | $77.92M derived: sum of 4 quarters · filed 2023-11-08 | ||
| 2022-06-30 | $3.72M 10-Q · filed 2023-08-09 | $3.72M 10-Q · filed 2023-08-09 | $77.92M derived: sum of 3 quarters · filed 2023-08-09 | $152.08M derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | $74.20M 10-Q · filed 2022-05-12 | $74.20M derived: sum of 2 quarters · filed 2023-03-29 | $148.36M derived: sum of 3 quarters · filed 2023-03-29 | $148.36M derived: sum of 4 quarters · filed 2023-03-29 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $74.16M derived: sum of 2 quarters · filed 2023-03-29 | $74.16M derived: sum of 3 quarters · filed 2023-03-29 | $74.16M 10-K · filed 2023-03-29 | ||
| 2021-09-30 | $74.16M 10-Q · filed 2022-11-09 | $74.16M derived: sum of 2 quarters · filed 2022-11-09 | $74.16M 10-Q · filed 2022-11-09 | |||
| 2021-08-26 | $74.20M 10-Q · filed 2023-11-08 | |||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-10 | $0.00 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |